Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Sun Pharma Advanced Research Company Limited (SPARC) is a prominent Indian biopharmaceutical firm specialising in innovative pharmaceutical preparation manufacturing. Headquartered in India, SPARC operates across key regions, focusing on the development of novel drugs and advanced formulations. Since its establishment, the company has achieved significant milestones in research and development, positioning itself as a leader in the pharmaceutical industry.
SPARC’s core offerings include specialised therapies and proprietary formulations that distinguish it within the competitive landscape. Its commitment to innovation has earned recognition for pioneering solutions in areas such as neurology, oncology, and ophthalmology. With a strong market presence and a focus on cutting-edge research, Sun Pharma Advanced Research Company Limited continues to advance its reputation as a key player in the global pharmaceutical sector.
-20 vs industry average
Sun Pharma Advanced Research Company Limited’s score of 22 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Sun Pharma Advanced Research Company Limited yet.
Sun Pharma Advanced Research Company Limited (SPARC), an organisation within the Pharmaceutical Preparation Manufacturing industry based in India, has reported no absolute greenhouse gas emissions for fiscal years 2023, 2024, and 2025. This indicates that for the reporting periods of fiscal year 2024 (ending 31 March 2024) and fiscal year 2025 (ending 31 March 2025), SPARC has disclosed zero kg CO2e for Scope 1 and Scope 2 emissions.
While specific emissions data is not available for Scope 3, the organisation's disclosures for these years note "scope_3/purchased_goods_and_services" as a missing data point.
SPARC has not publicly announced any specific carbon reduction targets or commitments, such as through the Science Based Targets initiative (SBTi) or the Climate Pledge. Further information regarding their climate strategy and initiatives may be found in their annual reports.
No climate goals have been disclosed for Sun Pharma Advanced Research Company Limited yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more